细胞株Cell Lines 61及完全培养基-BioVector NTCC质粒载体菌种细胞蛋白抗体基因保藏中心http://www.biovector.net
- 价 格:¥19200
- 货 号:NTCC-CV61
- 产 地:北京
- BioVector NTCC典型培养物保藏中心
- 联系人:Dr.Xu, Biovector NTCC Inc.
电话:400-800-2947 工作QQ:1843439339 (微信同号)
邮件:Biovector@163.com
手机:18901268599
地址:北京
- 已注册
细胞株Cell Lines-BioVector NTCC质粒载体菌种细胞蛋白抗体基因保藏中心
ID Hs 913(C).T
AC CVCL_1014
DR CLO; CLO_0004221
DR ATCC; CRL-7665
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-7665; true.
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 12
ST D13S317: 11
ST D16S539: 11,13
ST D5S818: 10
ST D7S820: 10
ST TH01: 8,9.3
ST TPOX: 9,11
ST vWA: 17,18
DI NCIt; C3043; Fibrosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_N665 ! Hs 913(A).T
OI CVCL_1013 ! Hs 913(B).T
OI CVCL_1015 ! Hs 913(D).T
OI CVCL_N664 ! Hs 913(E).T
OI CVCL_1016 ! Hs 913(F).T
OI CVCL_S016 ! Hs 913(G).Sk
OI CVCL_1017 ! Hs 913T
SX Male
CA Cancer cell line
//
ID Hs 913(D).T
AC CVCL_1015
DR CLO; CLO_0004222
DR ATCC; CRL-7666
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-7666; true.
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 12
ST D13S317: 11
ST D16S539: 11,13
ST D5S818: 10
ST D7S820: 10
ST TH01: 8,9.3
ST TPOX: 9,11
ST vWA: 17,18
DI NCIt; C3043; Fibrosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_N665 ! Hs 913(A).T
OI CVCL_1013 ! Hs 913(B).T
OI CVCL_1014 ! Hs 913(C).T
OI CVCL_N664 ! Hs 913(E).T
OI CVCL_1016 ! Hs 913(F).T
OI CVCL_S016 ! Hs 913(G).Sk
OI CVCL_1017 ! Hs 913T
SX Male
CA Cancer cell line
//
ID Hs 913(E).T
AC CVCL_N664
SY HS 913TE
DR ATCC; CRL-7667
RX PubMed=6500159;
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-7667; true.
DI NCIt; C3043; Fibrosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_N665 ! Hs 913(A).T
OI CVCL_1013 ! Hs 913(B).T
OI CVCL_1014 ! Hs 913(C).T
OI CVCL_1015 ! Hs 913(D).T
OI CVCL_1016 ! Hs 913(F).T
OI CVCL_S016 ! Hs 913(G).Sk
OI CVCL_1017 ! Hs 913T
SX Male
CA Cancer cell line
//
ID Hs 913(F).T
AC CVCL_1016
DR CLO; CLO_0004223
DR ATCC; CRL-7668
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 12
ST D13S317: 11
ST D16S539: 11,13
ST D5S818: 10
ST D7S820: 10
ST TH01: 8,9.3
ST TPOX: 9,11
ST vWA: 17,18
DI NCIt; C3043; Fibrosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_N665 ! Hs 913(A).T
OI CVCL_1013 ! Hs 913(B).T
OI CVCL_1014 ! Hs 913(C).T
OI CVCL_1015 ! Hs 913(D).T
OI CVCL_N664 ! Hs 913(E).T
OI CVCL_S016 ! Hs 913(G).Sk
OI CVCL_1017 ! Hs 913T
SX Male
CA Cancer cell line
//
ID Hs 913(G).Sk
AC CVCL_S016
DR ATCC; CRL-7662
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-7662; true.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_N665 ! Hs 913(A).T
OI CVCL_1013 ! Hs 913(B).T
OI CVCL_1014 ! Hs 913(C).T
OI CVCL_1015 ! Hs 913(D).T
OI CVCL_N664 ! Hs 913(E).T
OI CVCL_1016 ! Hs 913(F).T
OI CVCL_1017 ! Hs 913T
SX Male
CA Finite cell line
//
ID Hs 913T
AC CVCL_1017
SY Hs 913.T; Hs913T; HS913T
DR CLO; CLO_0004224
DR CLO; CLO_0004257
DR CLDB; cl4958
DR ATCC; HTB-152
DR BioSample; SAMN03472725
DR GEO; GSM1676301
DR GEO; GSM1701636
DR ICLC; HTL99012
RX PubMed=26351324;
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 12
ST D13S317: 11
ST D16S539: 13
ST D5S818: 10
ST D7S820: 10
ST TH01: 8,9.3
ST TPOX: 9,11
ST vWA: 17,18
DI NCIt; C3043; Fibrosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_N665 ! Hs 913(A).T
OI CVCL_1013 ! Hs 913(B).T
OI CVCL_1014 ! Hs 913(C).T
OI CVCL_1015 ! Hs 913(D).T
OI CVCL_N664 ! Hs 913(E).T
OI CVCL_1016 ! Hs 913(F).T
OI CVCL_S016 ! Hs 913(G).Sk
SX Male
CA Cancer cell line
//
ID Hs 914
AC CVCL_1018
DR CLO; CLO_0004225
DR ATCC; CRL-7895
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-7895; true.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Undefined cell line type
//
ID Hs 915
AC CVCL_1019
DR CLO; CLO_0004226
DR ATCC; CRL-7896
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-7896; true.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Undefined cell line type
//
ID Hs 916
AC CVCL_1020
DR CLO; CLO_0004227
DR ATCC; CRL-7897
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-7897; true.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Undefined cell line type
//
ID Hs 917.T
AC CVCL_1021
DR CLO; CLO_0004228
DR ATCC; CRL-7669
DR BioSample; SAMN03471183
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 10,13
ST D13S317: 11
ST D16S539: 11,12
ST D5S818: 9,12
ST D7S820: 10,12
ST TH01: 8,9.3
ST TPOX: 8
ST vWA: 14,16
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID Hs 918.Sk
AC CVCL_S017
DR ATCC; CRL-7670
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-7670; true.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID Hs 919.Sk
AC CVCL_1022
DR CLO; CLO_0004229
DR ATCC; CRL-7671
DR BioSample; SAMN03471186
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 11,12
ST D16S539: 11,13
ST D5S818: 12
ST D7S820: 10
ST TH01: 6,9.3
ST TPOX: 8,11
ST vWA: 16,17
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1023 ! Hs 919.T
SX Female
CA Finite cell line
//
ID Hs 919.T
AC CVCL_1023
SY Hs919.T
DR CLO; CLO_0004230
DR ATCC; CRL-7672
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 11,12
ST D16S539: 11,13
ST D5S818: 12
ST D7S820: 10
ST TH01: 6,9.3
ST TPOX: 8,11
ST vWA: 16,17
DI NCIt; C3297; Osteoid osteoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1022 ! Hs 919.Sk
SX Female
CA Cancer cell line
//
ID Hs 923.Sk
AC CVCL_S018
DR ATCC; CRL-7673
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-7673; true.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID Hs 924.LiT
AC CVCL_S019
DR ATCC; CRL-7675
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Population: Micronesian.
CC Discontinued: ATCC; CRL-7675; true.
CC Derived from metastatic site: Liver.
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1024 ! Hs 924.Sk
OI CVCL_S446 ! Hs 924.T
SX Female
CA Cancer cell line
//
ID Hs 924.Sk
AC CVCL_1024
DR CLO; CLO_0004231
DR ATCC; CRL-7674
DR BioSample; SAMN03471187
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Population: Micronesian.
CC Discontinued: ATCC; CRL-7674; true.
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 12,14
ST D13S317: 8,11
ST D16S539: 11,12
ST D5S818: 10,11
ST D7S820: 11,12
ST TH01: 9
ST TPOX: 8,11
ST vWA: 16,19
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_S019 ! Hs 924.LiT
OI CVCL_S446 ! Hs 924.T
SX Female
CA Finite cell line
//
ID Hs 924.T
AC CVCL_S446
SY HS 924.T
DR ATCC; CRL-7918
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Population: Micronesian.
CC Discontinued: ATCC; CRL-7918; true.
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1024 ! Hs 924.Sk
OI CVCL_S019 ! Hs 924.LiT
SX Female
CA Cancer cell line
//
ID Hs 925.Sk
AC CVCL_1025
DR CLO; CLO_0004232
DR ATCC; CRL-7676
DR BioSample; SAMN03471188
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 10,12
ST D13S317: 11,13
ST D16S539: 11,12
ST D5S818: 11,14
ST D7S820: 9,10
ST TH01: 8,9
ST TPOX: 8,11
ST vWA: 14,17
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1026 ! Hs 925.T
SX Male
CA Finite cell line
//
ID Hs 925.T
AC CVCL_1026
SY HS 925T; Hs925T
DR BTO; BTO:0002638
DR CLO; CLO_0004233
DR ATCC; CRL-7677
DR BioSample; SAMN03471189
RX PubMed=6500159;
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 11,13
ST D16S539: 11
ST D5S818: 14
ST D7S820: 9,10
ST TH01: 8,9
ST TPOX: 8
ST vWA: 14,17
DI NCIt; C7073; Paget disease
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1025 ! Hs 925.Sk
SX Male
CA Cancer cell line
//
ID Hs 926.T
AC CVCL_1027
SY Hs-926; Hs 926
DR CLO; CLO_0004234
DR ATCC; CRL-7678
DR BioSample; SAMN03471190
DR Cosmic; 1309334
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 9,14
ST D16S539: 11,12
ST D5S818: 11,13
ST D7S820: 10
ST TH01: 9,9.3
ST TPOX: 8,9
ST vWA: 14,15
DI NCIt; C8971; Embryonal rhabdomyosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID Hs 927.T
AC CVCL_S020
DR ATCC; CRL-7679
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-7679; true.
DI NCIt; C4872; Breast carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID Hs 928.T
AC CVCL_S021
DR ATCC; CRL-7680
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-7680; true.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Undefined cell line type
//
ID Hs 929.Sk
AC CVCL_1028
DR CLO; CLO_0004235
DR ATCC; CRL-7681
DR BioSample; SAMN03471133
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 10,11
ST D13S317: 9,12
ST D16S539: 12,13
ST D5S818: 12
ST D7S820: 12
ST TH01: 7,9.3
ST TPOX: 8,11
ST vWA: 16,17
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_S086 ! Hs 929.T
SX Male
CA Finite cell line
//
ID Hs 929.T
AC CVCL_S086
DR ATCC; CRL-7682
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-7682; true.
DI NCIt; C3016; Eosinophilic granuloma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1028 ! Hs 929.Sk
SX Male
CA Cancer cell line
//
ID Hs 93.Mu
AC CVCL_N602
DR ATCC; CRL-7061
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-7061; true.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1029 ! Hs 93.T
SX Male
CA Finite cell line
//
ID Hs 93.T
AC CVCL_1029
DR CLO; CLO_0004236
DR ATCC; CRL-7062
DR BioSample; SAMN03472659
DR GEO; GSM1676365
DR GEO; GSM1701695
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 10,12
ST D13S317: 11,12
ST D16S539: 11
ST D5S818: 10,11
ST D7S820: 11,13
ST TH01: 7,9
ST TPOX: 8,9
ST vWA: 14,16
DI NCIt; C3043; Fibrosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_N602 ! Hs 93.Mu
SX Male
CA Cancer cell line
//
ID Hs 933.T
AC CVCL_1030
SY HS 933T
DR CLO; CLO_0004237
DR ATCC; CRL-7683
RX PubMed=6500159;
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-7683; true.
DI NCIt; C3448; Wiskott-Aldrich syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Undefined cell line type
//
ID Hs 934.T
AC CVCL_1031
DR CLO; CLO_0004238
DR ATCC; CRL-7684
DR CCLE; HS934T_SKIN
DR GEO; GSM887128
DR GEO; GSM888199
RX PubMed=22460905;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 10,11
ST D16S539: 12
ST D5S818: 11
ST D7S820: 11,12
ST TH01: 7,8
ST TPOX: 8
ST vWA: 16,18
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1006 ! Hs 906(A).M
OI CVCL_1007 ! Hs 906(B).T
OI CVCL_S014 ! Hs 906(C).Sk
OI CVCL_S015 ! Hs 906(D).Mu
OI CVCL_1032 ! Hs 935.T
SX Female
CA Cancer cell line
//
ID Hs 935.T
AC CVCL_1032
SY HS 935.T
DR CLO; CLO_0004239
DR ATCC; CRL-7685
RX PubMed=6500159;
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-7685; true.
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 10,11
ST D16S539: 12
ST D5S818: 11
ST D7S820: 11,12
ST TH01: 7,8
ST TPOX: 8
ST vWA: 16,18
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1006 ! Hs 906(A).M
OI CVCL_1007 ! Hs 906(B).T
OI CVCL_S014 ! Hs 906(C).Sk
OI CVCL_S015 ! Hs 906(D).Mu
OI CVCL_1031 ! Hs 934.T
SX Female
CA Cancer cell line
//
ID Hs 936.T
AC CVCL_1033
SY HS 936T; Hs936T
DR CLO; CLO_0004240
DR EFO; EFO_0006594
DR ATCC; CRL-7686
DR BioSample; SAMN03471134
DR CCLE; HS936T_SKIN
DR GEO; GSM827554
DR GEO; GSM887129
DR GEO; GSM888200
RX PubMed=6500159;
RX PubMed=22460905;
RX PubMed=25485619;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Omics: Deep RNAseq analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 8,12
ST D13S317: 8
ST D16S539: 9,12
ST D5S818: 9,12
ST D7S820: 8,11
ST TH01: 7,9.3
ST TPOX: 8
ST vWA: 17,18
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID Hs 936.T(C1)
AC CVCL_1034
SY Hs 936.T
DR CLO; CLO_0004241
DR ATCC; CRL-7687
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 8,12
ST D13S317: 8
ST D16S539: 9,12
ST D5S818: 9,12
ST D7S820: 8,11
ST TH01: 7,9.3
ST TPOX: 8
ST vWA: 17,18
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1033 ! Hs 936.T
SX Male
CA Cancer cell line
//
ID Hs 938.T
AC CVCL_1035
SY HS 938T
DR CLO; CLO_0004242
DR ATCC; CRL-7688
RX PubMed=6500159;
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-7688; true.
DI NCIt; C3073; Gynecomastia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID Hs 939.Sk
AC CVCL_G023
SY Hs939SK
DR ATCC; CRL-7689
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-7689; true.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1036 ! Hs 939.T
SX Female
CA Finite cell line
//
ID Hs 939.T
AC CVCL_1036
SY HS-939-T; Hs939-T; Hs939T
DR CLO; CLO_0004243
DR ATCC; CRL-7690
DR BioSample; SAMN03471135
DR CCLE; HS939T_SKIN
DR Cosmic; 888862
DR Cosmic; 897478
DR Cosmic-CLP; 1298144
DR GDSC; 1298144
DR GEO; GSM887130
DR GEO; GSM888201
DR GEO; GSM1669900
RX PubMed=15009714;
RX PubMed=22460905;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): ATCC; Cosmic-CLP
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 8,11
ST D16S539: 9,11
ST D5S818: 11,12
ST D7S820: 8,11
ST TH01: 7,9.3
ST TPOX: 8
ST vWA: 14,20
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_G023 ! Hs 939.Sk
SX Female
CA Cancer cell line
//
ID Hs 94.Mu
AC CVCL_N604
DR ATCC; CRL-7063
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-7063; true.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1037 ! Hs 94.T
SX Female
CA Finite cell line
//
ID Hs 94.T
AC CVCL_1037
DR CLO; CLO_0004244
DR ATCC; CRL-7064
DR BioSample; SAMN03472660
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 12,13
ST D16S539: 9,12
ST D5S818: 11,12
ST D7S820: 8,9
ST TH01: 7,9.3
ST TPOX: 8
ST vWA: 17,18
DI NCIt; C3359; Rhabdomyosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_N604 ! Hs 94.Mu
SX Female
CA Cancer cell line
//
ID Hs 940.T
AC CVCL_1038
SY HS-940-T; Hs940-T; Hs-940; HS940
DR CLO; CLO_0004245
DR EFO; EFO_0006595
DR ATCC; CRL-7691
DR BioSample; SAMN03471136
DR CCLE; HS940T_SKIN
DR Cosmic; 706093
DR Cosmic; 888837
DR Cosmic; 897476
DR Cosmic-CLP; 1298145
DR GDSC; 1298145
DR GEO; GSM887131
DR GEO; GSM888202
DR GEO; GSM1669901
RX PubMed=10766161;
RX PubMed=15009714;
RX PubMed=22460905;
RX PubMed=25485619;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): ATCC; Cosmic-CLP
ST Amelogenin: X,Y
ST CSF1PO: 11
ST D13S317: 11,12
ST D16S539: 9,12
ST D5S818: 11
ST D7S820: 10
ST TH01: 9,9.3
ST TPOX: 8,11
ST vWA: 17,18
DI NCIt; C3510; Cutaneous melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID Hs 941.T
AC CVCL_1039
SY HS 941T
DR CLO; CLO_0004246
DR ATCC; CRL-7692
DR BioSample; SAMN03471137
RX PubMed=6500159;
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-7692; true.
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 10,12
ST D13S317: 12
ST D16S539: 9,10
ST D5S818: 12,13
ST D7S820: 11,12
ST TH01: 7
ST TPOX: 8,11
ST vWA: 14,16
DI NCIt; C4683; Dermatofibrosarcoma protuberans
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID Hs 944.T
AC CVCL_1040
SY HS 944T; HS944T; HS-944-T; HS 944; HS944
DR CLO; CLO_0004247
DR ATCC; CRL-7693
DR CCLE; HS944T_SKIN
DR GEO; GSM887132
DR GEO; GSM888203
DR GEO; GSM1669902
RX PubMed=6500159;
RX PubMed=10766161;
RX PubMed=15009714;
RX PubMed=22460905;
RX PubMed=25984343;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Doubling time: 30 hours (PubMed=25984343).
CC Omics: DNA methylation analysis.
CC Omics: shRNA library screening.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
DI NCIt; C3510; Cutaneous melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID Hs 946.Pl
AC CVCL_S087
DR ATCC; CRL-7694
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-7694; true.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID Hs 97.Fs
AC CVCL_1041
DR CLO; CLO_0004248
DR ATCC; CRL-7065
DR BioSample; SAMN03472661
DR ChEMBL-Cells; CHEMBL3308441
DR ChEMBL-Targets; CHEMBL614151
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 10,12
ST D13S317: 12,13
ST D16S539: 12
ST D5S818: 11,12
ST D7S820: 10,13
ST TH01: 7,9.3
ST TPOX: 8,11
ST vWA: 16
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID Hs 99.T
AC CVCL_S295
DR ATCC; CRL-7829
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-7829; true.
DI NCIt; C3359; Rhabdomyosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID hs-103-3
AC CVCL_8549
DR JCRB; JCRB1096
DR JCRB; NIHS0378
CC Discontinued: JCRB; NIHS0378; true.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0212 ! CHL
SX Female
CA Spontaneously immortalized cell line
//
ID HS-16
AC CVCL_J345
RX PubMed=8945624;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C2946; Chondrosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID hs-164-2
AC CVCL_8550
DR JCRB; JCRB1097
DR JCRB; NIHS0379
CC Discontinued: JCRB; NIHS0379; true.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0212 ! CHL
SX Female
CA Spontaneously immortalized cell line
//
ID hs-171-1
AC CVCL_8551
DR JCRB; JCRB1098
DR JCRB; NIHS0380
CC Discontinued: JCRB; NIHS0380; true.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0212 ! CHL
SX Female
CA Spontaneously immortalized cell line
//
ID hs-172-3
AC CVCL_8552
DR JCRB; JCRB1099
DR JCRB; NIHS0381
CC Discontinued: JCRB; NIHS0381; true.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0212 ! CHL
SX Female
CA Spontaneously immortalized cell line
//
ID HS-18
AC CVCL_J346
RX PubMed=8945624;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C27781; Myxoid liposarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HS-21
AC CVCL_0E36
SY HS21
RX Patent=US7129086;
RX PubMed=7849321;
CC Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6/E7 (pLXSN)].
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID HS-21 (subclone 1H3)
AC CVCL_G653
DR CLO; CLO_0004250
DR ATCC; HB-255
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID hs-211
AC CVCL_8553
DR JCRB; JCRB1100
DR JCRB; NIHS0382
CC Discontinued: JCRB; NIHS0382; true.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0212 ! CHL
SX Female
CA Spontaneously immortalized cell line
//
ID HS-22
AC CVCL_5527
DR JCRB; JCRB1215
CC Discontinued: JCRB; JCRB1215; probable.
CC Breed/subspecies: C3H/He.
OX NCBI_TaxID=10090; ! Mus musculus
CA Adult stem cell
//
ID hs-222-3
AC CVCL_8554
DR JCRB; JCRB1101
DR JCRB; NIHS0383
CC Discontinued: JCRB; NIHS0383; true.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0212 ! CHL
SX Female
CA Spontaneously immortalized cell line
//
ID HS-23
AC CVCL_0E35
SY HS23
DR ATCC; CRL-2495
RX Patent=US7129086;
RX PubMed=7849321;
CC Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6/E7 (pLXSN)].
CC Discontinued: ATCC; CRL-2495; true.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID HS-24
AC CVCL_Y110
SY HS 24
DR CGH-DB; 186-1
DR CGH-DB; 9173-4
DR Cosmic; 889099
RX PubMed=1316092;
RX PubMed=2201737;
RX PubMed=2695238;
RX PubMed=3327702;
RX PubMed=3678487;
RX PubMed=11414198;
RX PubMed=14581340;
RX PubMed=15746151;
DI NCIt; C3493; Squamous cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID HS-27
AC CVCL_0E34
SY HS27
DR TOKU-E; 1947
RX Patent=US7129086;
RX PubMed=2987007;
RX PubMed=7849321;
CC Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6/E7 (pLXSN)].
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID HS-27A
AC CVCL_3719
DR CLO; CLO_0004252
DR EFO; EFO_0005283
DR ATCC; CRL-2496
DR BioSample; SAMN03471594
DR ENCODE; ENCBS009ENC
CC Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6/E7 (pLXSN)].
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 10,11
ST D13S317: 11,13
ST D16S539: 11,12
ST D5S818: 12
ST D7S820: 12
ST TH01: 7,9
ST TPOX: 8,11
ST vWA: 18,19
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0E34 ! HS-27
SX Male
CA Transformed cell line
//
ID HS-30
AC CVCL_J347
RX PubMed=8945624;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3087; Hemangiopericytoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HS-42
AC CVCL_J348
RX PubMed=8945624;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C3233; Mesenchymoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HS-5
AC CVCL_3720
SY HS5
DR BTO; BTO:0004123
DR CLO; CLO_0004254
DR EFO; EFO_0005282
DR ATCC; CRL-11882
DR BioSample; SAMN03471343
DR ENCODE; ENCBS010ENC
DR NCBI_Iran; C626
RX Patent=US7129086;
RX PubMed=7849321;
CC Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6/E7 (pLXSN)].
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 10,11
ST D13S317: 11
ST D16S539: 11
ST D5S818: 12
ST D7S820: 12
ST TH01: 7,9
ST TPOX: 8
ST vWA: 18,19
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID HS-57
AC CVCL_Y111
SY HS 57
RX PubMed=2695238;
RX PubMed=3327702;
DI NCIt; C4878; Lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID HS-63
AC CVCL_DF13
SY HS 63
RX PubMed=3820188;
CC Monoclonal antibody target: UniProtKB; P26436; Human ACRV1.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID HS-67
AC CVCL_E705
SY HS67
DR dbMHC; 48901
DR ECACC; 94071425
DR IHW; IHW9277
DR IMGT/HLA; 10764
WW http://bioinformatics.hsanmartino.it/ecbr/cl277.html
CC Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID HS-72
AC CVCL_H243
RX PubMed=8267637;
OX NCBI_TaxID=10090; ! Mus musculus
CA Hybridoma
//
ID HS-80
AC CVCL_9708
RX PubMed=1320624;
CC From: Van Valen F.; University of Munster; Germany.
DI NCIt; C4817; Ewing sarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HS-ES-1
AC CVCL_8713
SY HS-ES-1M; HE-ES; HEES
DR CLO; CLO_0050148
DR BioSample; SAMN03471915
DR GEO; GSM1632456
DR GEO; GSM1632457
DR GEO; GSM1632460
DR GEO; GSM1632461
DR RCB; RCB2364
RX PubMed=9216728;
RX PubMed=16557275;
RX PubMed=26365879;
CC Omics: Deep RNAseq analysis.
ST Source(s): RCB
ST Amelogenin: X,Y
ST CSF1PO: 11,13
ST D13S317: 9
ST D16S539: 10
ST D5S818: 10
ST D7S820: 8,12
ST TH01: 7,9
ST TPOX: 8
ST vWA: 18
DI NCIt; C3714; Epithelioid sarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HS-ES-2M
AC CVCL_8714
DR CLO; CLO_0050149
DR BioSample; SAMN03471971
DR RCB; RCB2360
CC Derived from metastatic site: Lung.
ST Source(s): RCB
ST Amelogenin: X,Y
ST CSF1PO: 10,12
ST D13S317: 12
ST D16S539: 10,11
ST D5S818: 11
ST D7S820: 8
ST TH01: 7,9
ST TPOX: 8
ST vWA: 17,18
DI NCIt; C3714; Epithelioid sarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_8715 ! HS-ES-2R
SX Male
CA Cancer cell line
//
ID HS-ES-2R
AC CVCL_8715
DR CLO; CLO_0050147
DR BioSample; SAMN03471973
DR RCB; RCB2361
ST Source(s): RCB
ST Amelogenin: X,Y
ST CSF1PO: 10,12
ST D13S317: 12,14
ST D16S539: 10,11
ST D5S818: 11
ST D7S820: 8
ST TH01: 7,9
ST TPOX: 8
ST vWA: 18
DI NCIt; C3714; Epithelioid sarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_8714 ! HS-ES-2M
SX Male
CA Cancer cell line
//
ID HS-K
AC CVCL_K100
DR CLO; CLO_0050643
DR BioSample; SAMN03472340
DR RCB; RCB0159
ST Source(s): RCB
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 11,12
ST D16S539: 11,12
ST D5S818: 10,11
ST D7S820: 10
ST TH01: 9
ST TPOX: 8,12
ST vWA: 16
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID HS-MM
AC CVCL_W472
RX PubMed=2095846;
RX PubMed=8492224;
RX PubMed=10398127;
CC Doubling time: ~72 hours (PubMed=8492224).
CC Derived from metastatic site: Pleural effusion.
DI NCIt; C3745; Clear cell sarcoma of soft tissue
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HS-Os-1
AC CVCL_8716
DR CLO; CLO_0050022
DR BioSample; SAMN03470989
DR BioSample; SAMN03472027
DR RCB; RCB2229
RX PubMed=1679269;
RX PubMed=2085479;
ST Source(s): PubMed=25877200; RCB
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 11,11.3,12 (PubMed=25877200)
ST D13S317: 11,12 (RCB)
ST D16S539: 9,11
ST D18S51: 17
ST D19S433: 12
ST D21S11: 30,31.2
ST D2S1338: 18,25
ST D3S1358: 16
ST D5S818: 11,12
ST D7S820: 9,10
ST D8S1179: 13
ST FGA: 24,25
ST Penta D: 9,12
ST Penta E: 10
ST TH01: 9
ST TPOX: 8 (PubMed=25877200)
ST TPOX: 8,11 (RCB)
ST vWA: 15,18
DI NCIt; C9145; Osteosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HS-P
AC CVCL_5291
DR CLO; CLO_0050624
DR RCB; RCB1757
RX PubMed=11222016;
RX PubMed=11437512;
CC Breed/subspecies: Fischer 344/DuCrj.
DI NCIt; C60419; Rat histiocytic sarcoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
SX Male
CA Cancer cell line
//
ID HS-PSS
AC CVCL_8717
DR CLO; CLO_0051534
DR BioSample; SAMN03471914
DR RCB; RCB2362
ST Source(s): RCB
ST Amelogenin: X,Y
ST CSF1PO: 10,12
ST D13S317: 8,10
ST D16S539: 10
ST D5S818: 9,11
ST D7S820: 10,12
ST TH01: 6,9
ST TPOX: 8
ST vWA: 14,15
DI NCIt; C3798; Malignant peripheral nerve sheath tumor
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HS-RMS-1
AC CVCL_A791
RX PubMed=10853028;
RX PubMed=23882450;
CC Doubling time: ~60 hours (PubMed=10853028).
DI NCIt; C4258; Pleomorphic rhabdomyosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HS-RMS-2
AC CVCL_Y582
RX PubMed=22432055;
RX PubMed=23882450;
DI NCIt; C4258; Pleomorphic rhabdomyosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HS-Sch-2
AC CVCL_8718
SY HS-sch-2
DR CLO; CLO_0050146
DR BCRJ; 0376
DR BioSample; SAMN03472028
DR RCB; RCB2230
RX PubMed=10891546;
CC Characteristics: Has a TP53 p.Arg273His mutation.
CC Doubling time: ~56 hours (PubMed=10891546).
ST Source(s): RCB
ST Amelogenin: X
ST CSF1PO: 11,13
ST D13S317: 11
ST D16S539: 11,12
ST D5S818: 13
ST D7S820: 8,11
ST TH01: 6,7
ST TPOX: 8
ST vWA: 15,16
DI NCIt; C3798; Malignant peripheral nerve sheath tumor
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HS-Sultan
AC CVCL_2516
SY Hs-Sultan; HS-SULTAN; HS Sultan; HSSultan; H. S. Sultan; SULTAN; Sultan
DR BTO; BTO:0003035
DR CLO; CLO_0004264
DR EFO; EFO_0002199
DR CLDB; cl1723
DR ATCC; CRL-1484
DR BioSample; SAMN03151805
DR Cosmic; 759913
DR Cosmic; 846385
DR ECACC; 87012701
DR IGRhCellID; HSSultan
DR JCRB; JCRB9062
RX PubMed=4549735;
RX PubMed=6365856;
RX PubMed=10516762;
RX PubMed=11021758;
RX PubMed=12592342;
RX PubMed=20143388;
RX PubMed=25485619;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a Jiyoye derivative (PubMed=10516762, PubMed=12592342, PubMed=20143388). Originally thought to originate from a plasma cell myeloma.
CC Doubling time: 24 hours (PubMed=6365856).
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Omics: Deep RNAseq analysis.
CC Omics: SNP array analysis.
ST Source(s): ATCC; ECACC; JCRB
ST Amelogenin: X,Y
ST CSF1PO: 10,11
ST D13S317: 12
ST D16S539: 10,11
ST D5S818: 12
ST D7S820: 8,10
ST TH01: 7,9
ST TPOX: 6,8
ST vWA: 15,19
DI NCIt; C27694; Epstein-Barr virus-related Burkitt lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1317 ! Jiyoye
SX Male
CA Cancer cell line
//
ID HS-SY-2
AC CVCL_8719
SY HS-SY-II; HSSY-II; HSSYII
DR CLO; CLO_0050072
DR BioSample; SAMN03472029
DR Cosmic; 1217465
DR Cosmic; 1319811
DR Cosmic; 2307724
DR GEO; GSM482569
DR GEO; GSM1676333
DR GEO; GSM1701665
DR RCB; RCB2231
RX PubMed=1331610;
RX PubMed=24726063;
RX PubMed=26351324;
CC Derived from metastatic site: Pleural effusion.
ST Source(s): RCB
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 10
ST D16S539: 9
ST D5S818: 10,12
ST D7S820: 10,12
ST TH01: 8
ST TPOX: 8,12
ST vWA: 17,18
DI NCIt; C3400; Synovial sarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HS-SY-3
AC CVCL_N587
RX PubMed=10399965;
CC Doubling time: 120 hours (PubMed=10399965).
DI NCIt; C3400; Synovial sarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HS1-CLS
AC CVCL_5978
DR CLS; 300212/p588_HS1-CLS
ST Source(s): CLS
ST Amelogenin: X,Y
ST CSF1PO: 11,13
ST D13S317: 12
ST D16S539: 14
ST D18S51: 12,14
ST D21S11: 28,32
ST D3S1358: 17,18
ST D5S818: 13,16
ST D7S820: 11
ST D8S1179: 12,13,14
ST FGA: 21,22
ST Penta D: 9
ST Penta E: 11,13
ST TH01: 7
ST TPOX: 9
ST vWA: 17,18
DI NCIt; C5585; Skin sarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HS1001
AC CVCL_HF74
DR GEO; GSM1293445
DR GEO; GSM1293453
RX PubMed=24463987;
CC From: Karolinska Institutet; Stockholm; Sweden.
CC Omics: SNP array analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID HS181
AC CVCL_C229
SY KIe001-A
DR GEO; GSM1293456
DR GEO; GSM1293457
DR GEO; GSM1293458
DR GEO; GSM1293459
DR hPSCreg; KIe001-A
DR ISCR; 522
RX PubMed=12832363;
RX PubMed=17572666;
RX PubMed=18930318;
RX PubMed=20198446;
RX PubMed=24463987;
CC From: Karolinska Institutet; Stockholm; Sweden.
CC Registration: Swiss research registry; BAG-hES-IMP-0009.
CC Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC03-09.
CC Omics: SNP array analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID HS181-GFP
AC CVCL_EG08
RX PubMed=15345126;
CC From: Karolinska Institutet; Stockholm; Sweden.
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_C229 ! HS181
SX Female
CA Embryonic stem cell
//
ID HS207
AC CVCL_C230
SY KIe002-A
DR hPSCreg; KIe002-A
DR ISCR; 523
RX PubMed=12832363;
RX PubMed=20198446;
CC From: Karolinska Institutet; Stockholm; Sweden.
CC Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC06-21.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID HS235
AC CVCL_C231
SY KIe003-A
DR hPSCreg; KIe003-A
DR ISCR; 524
RX PubMed=20198446;
CC From: Karolinska Institutet; Stockholm; Sweden.
CC Registration: Swiss research registry; BAG-hES-IMP-0008.
CC Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC06-18.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID HS237
AC CVCL_C232
SY HS237 p135; KIe004-A
DR hPSCreg; KIe004-A
DR IGRhCellID; HS237%20p135
DR ISCR; 525
RX PubMed=20198446;
CC From: Karolinska Institutet; Stockholm; Sweden.
CC Registration: Swiss research registry; BAG-hES-IMP-0007.
CC Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC06-18.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID Hs27
AC CVCL_0335
AS CVCL_0710
SY Hs-27; Hs 27; Hs.27; HS27; Hs27F
DR CLO; CLO_0003910
DR CLO; CLO_0004251
DR MCCL; MCC:0000231
DR CLDB; cl1713
DR CLDB; cl5202
DR ATCC; CRL-1634
DR BioSample; SAMN03471409
DR ChEMBL-Cells; CHEMBL3307678
DR ChEMBL-Targets; CHEMBL614666
DR ECACC; 94041901
DR GEO; GSM114601
DR IZSLER; BS CL 136
RX PubMed=4472134;
ST Source(s): ATCC; ECACC
ST Amelogenin: X,Y
ST CSF1PO: 10,12
ST D13S317: 12,14
ST D16S539: 11,13
ST D5S818: 12
ST D7S820: 9,11
ST TH01: 7,8
ST TPOX: 6,8
ST vWA: 18
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID HS293
AC CVCL_C197
SY KIe005-A
DR hPSCreg; KIe005-A
DR IGRhCellID; HS293%20p26
DR IGRhCellID; HS293%20p60
DR ISCR; 526
RX PubMed=15790775;
RX PubMed=18930318;
RX PubMed=20198446;
CC From: Karolinska Institutet; Stockholm; Sweden.
CC Registration: Swiss research registry; BAG-hES-IMP-0010.
CC Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC06-18.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID HS306
AC CVCL_C198
SY KIe006-A
DR hPSCreg; KIe006-A
DR IGRhCellID; HS306%20p35
DR ISCR; 527
RX PubMed=15790775;
RX PubMed=20198446;
CC From: Karolinska Institutet; Stockholm; Sweden.
CC Registration: Swiss research registry; BAG-hES-IMP-0011.
CC Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC06-18.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID HS346
AC CVCL_C199
SY KIe007-A
DR hPSCreg; KIe007-A
DR ISCR; 528
RX PubMed=15790775;
RX PubMed=20198446;
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=564
CC From: Karolinska Institutet; Stockholm; Sweden.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-13-0201.
CC Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC07-20.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID HS351
AC CVCL_C200
SY KIe008-A
DR hPSCreg; KIe008-A
DR ISCR; 529
RX PubMed=15790775;
RX PubMed=20198446;
CC From: Karolinska Institutet; Stockholm; Sweden.
CC Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC07-20.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID HS356
AC CVCL_C201
SY KIe030-A
DR hPSCreg; KIe030-A
DR ISCR; 530
RX PubMed=15790775;
CC From: Karolinska Institutet; Stockholm; Sweden.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID HS360
AC CVCL_C202
SY KIe009-A
DR hPSCreg; KIe009-A
DR ISCR; 531
RX PubMed=15790775;
RX PubMed=20198446;
CC From: Karolinska Institutet; Stockholm; Sweden.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID HS361
AC CVCL_C203
SY KIe010-A
DR hPSCreg; KIe010-A
DR ISCR; 1361
RX PubMed=15790775;
RX PubMed=20198446;
CC From: Karolinska Institutet; Stockholm; Sweden.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID HS362
AC CVCL_C204
SY KIe011-A
DR hPSCreg; KIe011-A
DR ISCR; 532
RX PubMed=15790775;
RX PubMed=20198446;
CC From: Karolinska Institutet; Stockholm; Sweden.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
- 公告/新闻